METHOD FOR MINIMALLY INVASIVE INTRAUTERINE VESICO-AMNIAL BYPASS GRAFTING FOR DETERMINATION OF RESIDUAL URINE OUTPUT IN FETUS WITH FURTHER AMNIOINFUSION FOR PREVENTION OF LETHAL HYPOPLASIA OF LUNGS
	KOSOVTSOVA N V; PAVLICHENKO M V; MARKOVA T V; SYTYKH O N
	2020-08-20
专利权人	URALS MATERNITY INFANCY PROTECTION RES (URMA-Non-standard)
申请日期	2020-08-20
专利号	RU2748718-C1
成果简介	NOVELTY - Invention relates to medicine, namely to obstetrics and fetal surgery, and can be used for antenatal correction of the fetus in obstructive uropathy. To do this, under ultrasound control and general anesthesia, a vesico-amnimal shunt is inserted into the fetal bladder and amnioinfusion is performed. The vesico-amnimal shunt is inserted into the amniotic cavity and then into the fetal bladder with an introducer, the obturator is removed, the introducer is fixed in the working position, and the conductor with a stent is inserted into the introducer tube, while the extrusor squeezes the stent into the working area. In this case, the pigtail spiral is wrapped, which ensures its fixation in the organ. Then the introducer is removed, ultrasound monitoring of the fetal heartbeat and blood flow in the umbilical artery is carried out. The next day after the operation, a repeated ultrasound examination is performed: the condition of the fetus, the position of the stent, and the amount of amniotic fluid are assessed. With an amniotic fluid index of more than 3 cm, fetal kidney function is considered sufficient for satisfactory development of the fetal lungs, amnioinfusion is not indicated. The ultrasound examination is repeated after 7 days. If the amniotic fluid index is less than 3 cm, amnioinfusion is performed. Under aseptic conditions, a 0.9% sodium chloride solution in a volume of up to 1 liter is injected into the amniotic cavity. After the manipulation, dynamic ultrasound control is performed over the condition of the fetus and the amount of amniotic fluid. With a repeated decrease in the amount of amniotic fluid - the amniotic fluid index is less than 3 cm, amnioinfusion is performed again. USE - Medicine. ADVANTAGE - Ensures the elimination of lethal hypoplasia of the lungs due to the provision of the outflow of residual urine of the fetus and the replenishment of the lack of amniotic fluid using amnioinfusion. 1 cl, 2 ex
IPC 分类号	A61B-017/94
国家	俄罗斯
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/23103
专题	中国科学院新疆生态与地理研究所
作者单位	URALS MATERNITY INFANCY PROTECTION RES (URMA-Non-standard)
推荐引用方式 GB/T 7714	KOSOVTSOVA N V,PAVLICHENKO M V,MARKOVA T V,et al. METHOD FOR MINIMALLY INVASIVE INTRAUTERINE VESICO-AMNIAL BYPASS GRAFTING FOR DETERMINATION OF RESIDUAL URINE OUTPUT IN FETUS WITH FURTHER AMNIOINFUSION FOR PREVENTION OF LETHAL HYPOPLASIA OF LUNGS. RU2748718-C1[P]. 2020.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。